CircRNAs and CNS Gene Transfer
CircRNA 和 CNS 基因转移
基本信息
- 批准号:9898485
- 负责人:
- 金额:$ 37.58万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2022-04-30
- 项目状态:已结题
- 来源:
- 关键词:AffectAgeAnimal ModelAnimalsAntisense RNAAstrocytesBiogenesisBrainBrain regionC9ORF72Cell Culture TechniquesCellsClinicalClustered Regularly Interspaced Short Palindromic RepeatsCodeDataDetectionDevelopmentDiseaseDoseElementsEndoribonucleasesEngineeringExonsExonucleaseExpression ProfilingGene ExpressionGene Expression RegulationGene TransferGenesGenetic TranslationGrowth FactorHeartHepatotoxicityHumanIn VitroInsulinInternal Ribosome Entry SiteInverted Repeat SequencesLiverMediatingMicroRNAsMusNeurogliaNeurological ModelsNeuronal DifferentiationNeuronsOutcomePatientsPlasmidsPopulationPre-Clinical ModelProductionRNARNA ProcessingRNA SplicingRecombinant adeno-associated virus (rAAV)SafetySynapsesSystemTestingTherapeuticTissuesToxic effectTransaminasesTranslationsTreatment EfficacyUntranslated RNAWorkadeno-associated viral vectorbasecell agecell typecircular RNAdesignfrontotemporal lobar dementia-amyotrophic lateral sclerosisgene therapy clinical trialimprovedmRNA Stabilitymouse modelnervous system disorderneuron developmentneurotoxicneurotoxicitynovelnucleic acid-based therapeuticsoverexpressionprotein expressionpublic health relevanceresponsesmall hairpin RNAtherapeutic proteintime intervalvectorvector genome
项目摘要
ABSTRACT: Circular RNAs (circRNAs) are an emerging class of RNA molecules with potential for prolonged expression due to their inaccessibility to exonucleases. Recent studies dissecting circRNA biogenesis have found inverted repeat sequences such as ALU repeats in humans, flanking a large number of exons that are subject to circularization and have shown these cis-elements as well as splicing machinery are essential for their circularization. In the mammalian brain, circRNAs appear to be highly abundant and dynamically regulated by development and plasticity. In particular, they appear to be enriched at the synapses and during neuronal differentiation and development. Despite these exciting advances, no systems for studying biogenesis of synthetic circRNAs in the brain and models of neurological disease. Specific aims for the current proposal are focused on engineering circRNA expression systems, studying factors affecting circRNA biogenesis efficiency in the brain, and utilizing these systems to interrogate deregulation of splicing and RNA-induced neurotoxicity seen in a C9orf72 Hexanucleotide Repeat Expansion mouse model of Frontotemporal Dementia (FTD) and Amyotrophic Lateral Sclerosis (ALS). CircRNAs capable of disrupting the neurotoxic RNA foci seen in these mouse models may enable design of therapeutics for FTD/ALS, where the C9orf72 expansion is prevalent and believed to be causative. Overall, the current proposal will help develop new strategies for efficient biogenesis of circRNAs in animal models, which are likely to help understand factors affecting circRNA biogenesis in the mammalian brain as well as usher in a new class of nucleic acid therapeutics based on circular RNAs.
摘要:圆形RNA(CIRCRNA)是一类新兴的RNA分子,由于其对核酸外切的核酸酶的无法访问,其可能会长时间表达。最近解剖circrna生物发生的研究发现了倒重复序列,例如人类中的Alu重复序列,两侧是大量受圆形外显子的影响,并显示了这些顺式元素以及拼接机械对于它们的循环化至关重要。在哺乳动物的大脑中,circrnas似乎高度丰富,并且受发展和可塑性的动态调节。特别是,它们似乎在突触和神经元分化和发育过程中富含。尽管取得了令人兴奋的进步,但仍未用于研究大脑中合成CIRCRNA的生物发生和神经系统疾病的模型。 Specific aims for the current proposal are focused on engineering circRNA expression systems, studying factors affecting circRNA biogenesis efficiency in the brain, and utilizing these systems to interrogate deregulation of splicing and RNA-induced neurotoxicity seen in a C9orf72 Hexanucleotide Repeat Expansion mouse model of Frontotemporal Dementia (FTD) and Amyotrophic Lateral Sclerosis (ALS)。能够破坏这些小鼠模型中看到的神经毒性RNA焦点的CIRCRNA可能会为FTD/ALS设计治疗,其中C9ORF72膨胀很普遍,并且认为是造成病因。总体而言,当前的建议将有助于制定新的策略,以有效地在动物模型中生物发生CIRCRNA,这可能有助于理解影响哺乳动物大脑中Circrna生物发生的因素,并迎来了基于圆环RNA的新型核酸疗法。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Aravind Asokan其他文献
Aravind Asokan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Aravind Asokan', 18)}}的其他基金
Engineering the biology of AAV secretion and production
AAV 分泌和生产的生物学工程
- 批准号:
10656028 - 财政年份:2023
- 资助金额:
$ 37.58万 - 项目类别:
Evolving Novel AAV Vectors for Gene Therapy to Cure HIV
进化新型 AAV 载体用于基因治疗以治愈 HIV
- 批准号:
10640060 - 财政年份:2022
- 资助金额:
$ 37.58万 - 项目类别:
Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors
通过腺相关病毒载体的离体灌注递送同种异体肾的基因工程
- 批准号:
10667569 - 财政年份:2022
- 资助金额:
$ 37.58万 - 项目类别:
Genetic engineering of kidney allografts by ex vivo perfusion delivery of adeno-associated viral vectors
通过腺相关病毒载体的离体灌注递送同种异体肾的基因工程
- 批准号:
10480356 - 财政年份:2022
- 资助金额:
$ 37.58万 - 项目类别:
Evolving Novel AAV Vectors for Gene Therapy to Cure HIV
进化新型 AAV 载体用于基因治疗以治愈 HIV
- 批准号:
10371617 - 财政年份:2022
- 资助金额:
$ 37.58万 - 项目类别:
Evolving High Potency AAV Vectors for Neuromuscular Genome Editing
进化用于神经肌肉基因组编辑的高效 AAV 载体
- 批准号:
10482406 - 财政年份:2018
- 资助金额:
$ 37.58万 - 项目类别:
Evolving High Potency AAV Vectors for Neuromuscular Genome Editing
进化用于神经肌肉基因组编辑的高效 AAV 载体
- 批准号:
10465740 - 财政年份:2018
- 资助金额:
$ 37.58万 - 项目类别:
相似国自然基金
无线供能边缘网络中基于信息年龄的能量与数据协同调度算法研究
- 批准号:62372118
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
CHCHD2在年龄相关肝脏胆固醇代谢紊乱中的作用及机制
- 批准号:82300679
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
颗粒细胞棕榈酰化蛋白FXR1靶向CX43mRNA在年龄相关卵母细胞质量下降中的机制研究
- 批准号:82301784
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
年龄相关性黄斑变性治疗中双靶向药物递释策略及其机制研究
- 批准号:82301217
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Role of intestinal serotonin transporter in post traumatic stress disorder
肠道血清素转运蛋白在创伤后应激障碍中的作用
- 批准号:
10590033 - 财政年份:2024
- 资助金额:
$ 37.58万 - 项目类别:
Childhood trauma, hippocampal function, and anhedonia among those at heightened risk for psychosis
精神病高危人群中的童年创伤、海马功能和快感缺失
- 批准号:
10825287 - 财政年份:2024
- 资助金额:
$ 37.58万 - 项目类别:
Understanding the Mechanisms and Consequences of Basement Membrane Aging in Vivo
了解体内基底膜老化的机制和后果
- 批准号:
10465010 - 财政年份:2023
- 资助金额:
$ 37.58万 - 项目类别:
A National NHP Embryo Resource of Human Genetic Disease Models
国家NHP人类遗传病模型胚胎资源
- 批准号:
10556087 - 财政年份:2023
- 资助金额:
$ 37.58万 - 项目类别:
Sustained eIF5A hypusination at the core of brain metabolic dysfunction in TDP-43 proteinopathies
持续的 eIF5A 抑制是 TDP-43 蛋白病脑代谢功能障碍的核心
- 批准号:
10557547 - 财政年份:2023
- 资助金额:
$ 37.58万 - 项目类别: